Cooperation, Compliance, And Consequences: Inside DOJ's $46 Million Veloxis Settlement
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Wed, 26 August 2026
What it is about
Task Force To Eliminate FraudPayments ProgramDepartment Of JusticeVeloxis Pharmaceuticals IncDepartment Of Health Human ServicesCenters For Medicare Medicaid ServicesVeloxis PharmaceuticalsNational Fraud Enforcement DivisionCompanies ShouldOffice Of InspectorHealth Care EnforcementPayments Program SunshineMassachusetts, United States
Who published it, and when
How it spread - 1 original report
Wed, 26 August 2026
1 report- mondaq.com22:37first to report
The Department of Justice's $46 million resolution with Veloxis Pharmaceuticals reveals how aggressive marketing tactics involving kickbacks to healthcare professionals and specialty pharmacies can trigger both criminal and civil enforcement actions. This case demonstrates the government's willingness to pursue pharmaceutical manufacturers under multiple legal frameworks, including the Anti-Kickback Statute, False Claims Act, and Open Payments Program.